These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 23991042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):941-8. PubMed ID: 25825481
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S, Zheng Z, Tang X, Peng L, Luo Y, Dong R, Zhao Y, Liu J.
    J Comput Assist Tomogr; 2015 Jun 05; 39(6):969-74. PubMed ID: 26248154
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biological Variability of Estimated GFR and Albuminuria in CKD.
    Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY, Feldman HI, Xie D, Liu KD, Mifflin TE, Eckfeldt JH, Kimmel PL, Vasan RS, Bonventre JV, Inker LA, Coresh J, Chronic Kidney Disease Biomarkers Consortium Investigators.
    Am J Kidney Dis; 2018 Oct 05; 72(4):538-546. PubMed ID: 30031564
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.
    Joosten MM, Pai JK, Bertoia ML, Gansevoort RT, Bakker SJ, Cooke JP, Rimm EB, Mukamal KJ.
    J Am Heart Assoc; 2014 Jun 30; 3(4):. PubMed ID: 24980133
    [Abstract] [Full Text] [Related]

  • 11. Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin.
    Wong J, Sridharan S, Berdeprado J, Vilar E, Viljoen A, Wellsted D, Farrington K.
    Kidney Int; 2016 May 30; 89(5):1090-1098. PubMed ID: 26924065
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
    He J, Ning HB, Zeng YL, Li W, Li K, Shang J.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep 20; 24(9):643-646. PubMed ID: 27788718
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Change in novel filtration markers and risk of ESRD.
    Rebholz CM, Grams ME, Matsushita K, Selvin E, Coresh J.
    Am J Kidney Dis; 2015 Jul 20; 66(1):47-54. PubMed ID: 25542414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate.
    Jovanović D, Krstivojević P, Obradović I, Durdević V, Dukanović L.
    Ren Fail; 2003 Jan 20; 25(1):123-33. PubMed ID: 12617340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.